Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
9.15M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
1.8M
-
Shares change
-
+26.5K
-
Total reported value, excl. options
-
$5.46M
-
Value change
-
+$80.8K
-
Number of buys
-
12
-
Number of sells
-
-5
-
Price
-
$3.04
Significant Holders of AYTU BIOPHARMA, INC - Common Stock (AYTU) as of Q1 2024
28 filings reported holding AYTU - AYTU BIOPHARMA, INC - Common Stock as of Q1 2024.
AYTU BIOPHARMA, INC - Common Stock (AYTU) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.8M shares
of 9.15M outstanding shares and own 19.62% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.09M shares), Stonepine Capital Management, LLC (472K shares), RENAISSANCE TECHNOLOGIES LLC (71.3K shares), GEODE CAPITAL MANAGEMENT, LLC (34.6K shares), VANGUARD GROUP INC (27.9K shares), BlackRock Inc. (22.8K shares), DIMENSIONAL FUND ADVISORS LP (15.2K shares), ACADIAN ASSET MANAGEMENT LLC (14.6K shares), NORTHERN TRUST CORP (14.6K shares), and GOLDMAN SACHS GROUP INC (13.9K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.